Wedbush lowered the firm’s price target on Petco to $6 from $9 and keeps an Outperform rating on the shares. Petco reported Q2 results that beat sales and EBITDA expectations, but the 2H sales and margin outlook was negative, calling for continued discretionary demand pressure, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on WOOF:
- Petco price target lowered to $7 from $11 at Wells Fargo
- Petco price target lowered to $8 from $11 at Baird
- Petco Healthcare (NASDAQ: WOOF) Stumbles after Q2 Earnings Drop 62.5%, Future Projections Disappoint
- Petco falls 8% to $6.00 after cutting FY23 EPS guidance
- Petco Health + Wellness Company, Inc. Reports Second Quarter Earnings